Sanofi's VTE avatar

Digital Pharma: online campaign directory updated

pharmafile | March 4, 2011 | Feature | Medical Communications, Sales and Marketing Digital Pharma blog, Novartis, Pfizer, Sanofi-Aventis, VTE, diabetes, erectile dysfunction, pharmacist educaiton, venous thromboembolism, viagra 

The latest update to the Digital Pharma links directory covers its online campaigns section and includes a pharmacist networking portal from Sanofi, Novartis’ diabetes information site and a new erectile dysfunction campaign from Pfizer.

Sanofi-Aventis has launched a combined networking and continuing professional development (CPD) site for UK pharmacists involved with venous thromboembolism.

The  Linkup VTE portal incorporates avatar technology to help bring its subject to life and is aimed at clinical pharmacists looking to help their Foundation Trust meet the government’s new targets for VTE prevention.

Sanofi, which markets the anticoagulant Plavix (clopidogrel) with partner Bristol-Myers Squibb, collaborated with the UK’s Clinical Pharmacy Association Haemostasis, Anticoagulation and Thrombosis committee (UKCPA HAT) and Keele University School of Pharmacy on the new CPD programme.

Sanofi has created the site to mimic popular social networking sites in order to ensure pharmacists will feel “comfortable and familiar” in using Linkup VTE.

Its CPD programme allows the user to interact via free text questions with three different computer generated avatar colleagues (a ward nurse, a junior doctor and a senior consultant). The virtual colleagues have been programmed to offer specific dialogue and will respond with audio and visual responses (all based on published guidance) that simulate real-world situations.

The user will also be able to print a transcript of the feedback, along with their questions and colleague responses for inclusion in the pharmacist’s CPD file.

Pfizer offers to prepare patients to have ED conversations with their doctor

Pfizer UK has a new online campaign that takes aim at men’s reluctance to discuss sexual health issues and erectile dysfunction (ED) in particular.

The company, whose Viagra is the world’s best known ED treatment, says it wants to help men who are reluctant to discuss their erection difficulties.

Hard Words includes a unique interactive video feature that enables users to set up a trial run conversation with a doctor giving them the reassurance and confidence to take action and book an appointment with their GP.

The site has been funded and developed by Pfizer, which says it has “a fundamental role to play in helping people to make informed decisions about their health through access to impartial information” because of its knowledge and understanding of health issues.

“With so much conflicting and confusing information available on the internet, it can often be difficult for men to know where to turn to for genuine and credible information about ED,” the company said.

“ has been created to fill this information void and help men overcome the hard words that have become barriers preventing them from seeking help for their ED. We hope the website will give men the confidence to work with their healthcare professional to overcome their erection problems.”

The website also contains fictional testimonial/confessional videos and various widgets in the form of animated graphics and quizzes to engage the user and dispel common myths about ED. 

Novartis disease information site tackles diabetes

Still in the UK and Novartis has launched a disease information site for healthcare professionals, patients and the general public.

Gladstone will initially focus on the management of type II diabetes, with COPD resources to follow, and materials for doctors include clinical case studies and patient education materials.

Novartis is also promoting the site as a CPD resource for GPs and has partnered with to offer Your Voice, a “closed online ideas forum”, through which healthcare professionals can submit feedback about the site or ideas on how Novartis can help improve outcomes in primary care.

Digital Pharma campaign roundup

Other campaigns in this update of the Digital Pharma links directory include:

• Roche’s French flu awareness site

• Merck Serono’s European Life Beyond Chemotherapy campaign

• Alois, a French site from Pfizer and Eisai about Alzheimer’s disease

• And sites from GlaxoSmithKline, Boehringer Ingelheim, Novartis, Leo Pharma, Bristol-Myers Squibb

Further updates are planned shortly for the Digital Pharma links directory’s sections on mobile apps, Facebook, Twitter, YouTube, blogs and other digital initiatives from the pharmaceutical industry.

Dominic Tyer is web editor for Pharmafocus and and the author of the Digital Pharma blog He can be contacted via email, Twitter or LinkedIn.

Related Content

FDA approves Novartis’ Fabhalta for PNH treatment

Novartis has announced that the US Food and Drug Administration has approved Fabhalta (iptacopan) as …

Roche to acquire Carmot Therapeutics for $2.7bn

Roche has announced that it has entered into a definitive merger agreement with Carmot Therapeutics, …

CDC Advisory Committee recommends Pfizer’s RSV vaccine

Pfizer has announced that the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee …

Latest content